Stock picks by Sameet Chavan: Buy ITC, sell Dr Lal PathLabs

Dr Lal PathLabs' stock seems to have lost its sheen now as we are seeing consistent corrective moves over the past few weeks

Nifty Outlook

Yet another Monday kick-started with a gap and this time it surprised pleasantly in the upward direction. Subsequently, the benchmark index consolidated within a range throughout the day by maintaining its positive posture. Amongst a good stock specific action, Nifty managed to reclaim the 14,950 mark on the first day itself. Everything looked rosy and things were very much in place for a breakout from the recent congestion phase. However, all of a sudden, the global markets looked a bit shaky and started correcting sharply from their recent highs. This had a rub off effect on our markets which